興科蓉醫藥：年報2020.pdf

1、(Incorporated under the laws of the Cayman Islands with limited liability)(根據開曼群島法例註冊成立的有限公司)Stock Code 股份代號:6833ANNUAL REPORT2020年報Sinco Pharmaceuticals Holdings Limited 兴科蓉医药控股有限公司2020 Annual Report 年報EPORT報Contents目錄2Corporate Information公司資料4Financial Highlights財務摘要6Chairman s Statement主席報告9Mana

2、gement Discussion and Analysis管理層討論及分析31Director and Senior Management董事及高級管理層37Report of the Directors董事會報告51Corporate Governance Report企業管治報告75Independent Auditor s Report獨立核數師報告81Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表82Consolidated Statement of Financi

3、al Position綜合財務狀況表84Consolidated Statement of Changes in Equity綜合權益變動表85Consolidated Statement of Cash Flows綜合現金流量表88Notes to Financial Statements財務報表附註182Definitions釋義2Sinco Pharmaceuticals Holdings Limited Annual Report 2020Corporate Information公司資料BOARD OF DIRECTORSExecutive DirectorsMr.Huang Xia

4、ngbin(Chairman and Co-Chief Executive Officer)Ms.Zhang Zhijie(resigned on 8 January 2021)Independent Non-executive DirectorsMr.Lau Ying KitMr.Liu WenfangMr.Wang QingMr.Bai Zhizhong(appointed on 1 September 2020)AUDIT COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Liu WenfangMr.Wang QingMr.Bai Zhizhong(appoint

5、ed on September 2020)REMUNERATION COMMITTEEMr.Wang Qing(Chairman)Ms.Zhang Zhijie(resigned on 8 January 2021)Mr.Liu WenfangMr.Bai Zhizhong(appointed on 8 January 2021)NOMINATION COMMITTEEMr.Huang Xiangbin(Chairman)Mr.Liu WenfangMr.Lau Ying KitINTERNAL CONTROL AND CORPORATE GOVERNANCE COMMITTEEMr.Lau

6、Ying Kit(Chairman)Mr.Wang QingMr.Liu WenfangMr.Bai Zhizhong(appointed on 1 September 2020)AUTHORISED REPRESENTATIVESMr.Huang XiangbinMs.Li Ching Yi(resigned on 22 January 2021)Ms.Wong Yik Han(appointed on 22 January 2021 and resigned on 31 March 2021)Mr.Li Kin Wai(appointed on 31 March 2021)JOINT CO